Strata Skin Sciences Stock EBITDA
| SSKN Stock | USD 0.40 0.03 8.11% |
STRATA Skin Sciences fundamentals help investors to digest information that contributes to STRATA Skin's financial success or failures. It also enables traders to predict the movement of STRATA Stock. The fundamental analysis module provides a way to measure STRATA Skin's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to STRATA Skin stock.
STRATA |
STRATA Skin Sciences Company EBITDA Analysis
STRATA Skin's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current STRATA Skin EBITDA | (418 K) |
Most of STRATA Skin's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, STRATA Skin Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, STRATA Skin Sciences reported earnings before interest,tax, depreciation and amortization of (418,000). This is 100.05% lower than that of the Health Care Equipment & Supplies sector and 100.07% lower than that of the Health Care industry. The ebitda for all United States stocks is 100.01% higher than that of the company.
STRATA EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses STRATA Skin's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of STRATA Skin could also be used in its relative valuation, which is a method of valuing STRATA Skin by comparing valuation metrics of similar companies.STRATA Skin is currently under evaluation in ebitda category among its peers.
STRATA Fundamentals
| Return On Equity | -0.63 | ||||
| Return On Asset | -0.0838 | ||||
| Profit Margin | (0.32) % | ||||
| Operating Margin | (0.13) % | ||||
| Current Valuation | 23.57 M | ||||
| Shares Outstanding | 35.06 M | ||||
| Shares Owned By Insiders | 6.04 % | ||||
| Shares Owned By Institutions | 66.30 % | ||||
| Number Of Shares Shorted | 76.94 K | ||||
| Price To Earning | (0.49) X | ||||
| Price To Book | 1.41 X | ||||
| Price To Sales | 0.54 X | ||||
| Revenue | 33.36 M | ||||
| Gross Profit | 19.85 M | ||||
| EBITDA | (418 K) | ||||
| Net Income | (10.83 M) | ||||
| Cash And Equivalents | 10.04 M | ||||
| Cash Per Share | 0.29 X | ||||
| Total Debt | 15.63 M | ||||
| Debt To Equity | 0.35 % | ||||
| Current Ratio | 1.30 X | ||||
| Book Value Per Share | 0.36 X | ||||
| Cash Flow From Operations | (519 K) | ||||
| Short Ratio | 0.87 X | ||||
| Earnings Per Share | (0.34) X | ||||
| Price To Earnings To Growth | (0.02) X | ||||
| Target Price | 2.6 | ||||
| Number Of Employees | 99 | ||||
| Beta | 1.54 | ||||
| Market Capitalization | 13.02 M | ||||
| Total Asset | 42.02 M | ||||
| Retained Earnings | (238.06 M) | ||||
| Working Capital | 3.37 M | ||||
| Current Asset | 9.39 M | ||||
| Current Liabilities | 4.62 M | ||||
| Net Asset | 42.02 M |
About STRATA Skin Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze STRATA Skin Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of STRATA Skin using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of STRATA Skin Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in STRATA Stock
When determining whether STRATA Skin Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STRATA Skin's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Strata Skin Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Strata Skin Sciences Stock:Check out STRATA Skin Piotroski F Score and STRATA Skin Altman Z Score analysis. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.